Evidence map›Paper›PMID 39634298›Full record

ArticleNanophotonics (Berlin, Germany)2022

Three birds with one stone: oxygen self-supply engineering palladium nanocluster/titanium carbide hybrid for single-NIR laser-triggered synergistic photodynamic-photothermal therapy.

Shanshan Dang, Yanmei Mo, Junqing Zeng, Yunjie Xu, Zhongjian Xie, Han Zhang, Bin Zhang, Guohui Nie

Abstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Copper decorated TiNanophotonics (Berlin, Germany) · 2022
    Article
  4. Article
  5. Novel two-dimensional materials based bio-nanophotonics.Nanophotonics (Berlin, Germany) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shanshan DangShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.
Yanmei MoShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.
Junqing ZengGraduate Collaborative Training Base of Shenzhen Second' People's Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China, doczgjnqi@126.com.
Yunjie XuShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.
Zhongjian XieShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.ORCID https://orcid.org/0000-0002-4328-1303
Han ZhangShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.ORCID https://orcid.org/0000-0002-9131-9767
Bin ZhangShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.ORCID https://orcid.org/0000-0002-2112-2555
Guohui NieShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Institute of Translational Medicine, Department of Otolaryngology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Health Science Center, Institute of Microscale Optoelectronics, Shenzhen 518035, China,718426557@qq.com 2807751582@qq.com xuyunjie87@163.com zjxie2011@163.com.ORCID https://orcid.org/0000-0001-7050-8094

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a key branch of the cross-discipline biophotonics, phototherapy, including photodynamic therapy (PDT), and photothermal therapy (PTT), is promising in biomedicine and visible light-driving PDT has been applied to clinical treatment. However, extensive applications of phototherapy are limited by the hypoxic microenvironment, laser penetration depth, and potential complexity for combined PDT/PTT. Thus, NIR-responsive oxygen self-supply nanocomposites functionalized with photosensitizers for achieving simultaneous in-depth PDT/PTT are urgently required. Herein, a multifunctional platform has been fabricated by co-immobilizing monodispersed ultrasmall Pd nanoclusters and a photosensitizer 5,10,15,20-Tetrakis (4-Aminophenyl)-21H,23H Porphyrin (Thp) on the surface of Ti

Indexed as

2D nanosheetsenhanced photodynamic therapymolecular oxygenphotothermal therapyreactive oxygen species

Identifiers

PMID39634298
PMCPMC11501429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.